Variant report
Variant | esv3332653 |
---|---|
Chromosome Location | chr6:161927173-161929569 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs562548778 | chr6:161927177-161927178 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs531555744 | chr6:161927187-161927188 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs9458290 | chr6:161927199-161927200 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs560892684 | chr6:161927216-161927217 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs9458291 | chr6:161927232-161927233 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs10806747 | chr6:161927259-161927260 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs566514260 | chr6:161927354-161927355 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs182774529 | chr6:161927359-161927360 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs369661569 | chr6:161927431-161927432 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs372440087 | chr6:161927472-161927473 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs550634116 | chr6:161927500-161927501 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs141060868 | chr6:161927501-161927502 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs9456679 | chr6:161927524-161927525 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs116117177 | chr6:161927533-161927534 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs534193896 | chr6:161927537-161927538 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs150267839 | chr6:161927538-161927539 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs569858868 | chr6:161927541-161927542 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs539933988 | chr6:161927555-161927556 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs138981169 | chr6:161927578-161927579 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs576122804 | chr6:161927580-161927581 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs188334590 | chr6:161927611-161927612 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs4708911 | chr6:161927673-161927674 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs4708912 | chr6:161927706-161927707 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs150290258 | chr6:161927709-161927710 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs540127125 | chr6:161927715-161927716 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs4708913 | chr6:161927724-161927725 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs184081938 | chr6:161927750-161927751 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs4709533 | chr6:161927768-161927769 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs481910 | chr6:161927794-161927795 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs531420841 | chr6:161927800-161927801 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs76645778 | chr6:161927821-161927822 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs482675 | chr6:161927831-161927832 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs505845 | chr6:161927859-161927860 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs1474767 | chr6:161927875-161927876 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs482845 | chr6:161927886-161927887 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs549021300 | chr6:161927889-161927890 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs568969463 | chr6:161927951-161927952 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs556319831 | chr6:161927953-161927954 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs576166021 | chr6:161927959-161927960 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs149431555 | chr6:161927960-161927961 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs367736611 | chr6:161927981-161927982 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs16892658 | chr6:161928034-161928035 | Weak transcription Enhancers ZNF genes & repeats | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs572303702 | chr6:161928047-161928048 | Weak transcription Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
44 | rs545904436 | chr6:161928123-161928124 | Weak transcription Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
45 | rs28420593 | chr6:161928140-161928141 | Weak transcription Enhancers ZNF genes & repeats | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs147446380 | chr6:161928182-161928183 | Weak transcription Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
47 | rs35631994 | chr6:161928183-161928184 | Weak transcription Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
48 | rs577045090 | chr6:161928200-161928201 | Weak transcription Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
49 | rs138309085 | chr6:161928251-161928252 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs73591656 | chr6:161928309-161928310 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Ependymoma | 16718352 | CNVD |
Gastric cancer | 17908304 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Developmental delay | 19490664 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Leukemia | 18688285 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Esophageal cancer | 21851588 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Breast cancer | 17133270 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Developmental delay | 21147756 | CNVD |
Chordoma | 18071362 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Autism | 22241247 | CNVD |
Breast cancer | 16397240 | CNVD |
Atherosclerosis | 21956041 | CNVD |
Maculopathy | 20981449 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Astrocytoma | 16205629 | CNVD |
Parkinson disease | 17160897 | CNVD |
Cancer | 20164920 | CNVD |
Breast cancer | 22522925 | CNVD |
Schizophrenia | 20838587 | CNVD |
Early-onset parkinson disease | 21993715 | CNVD |
Glioblastoma | 18772890 | CNVD |
Pancreatic cancer | 20981101 | CNVD |
Autism | 21360662 | CNVD |
Melanoma | 20877625 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Intellectual disability | 22102821 | CNVD |
Parkinson disease | 0 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:161904800-161927800 | Weak transcription | Fetal Kidney | kidney |
2 | chr6:161925400-161927600 | Weak transcription | Psoas Muscle | Psoas |
3 | chr6:161925400-161931600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr6:161927600-161928000 | Enhancers | Fetal Muscle Trunk | muscle |
5 | chr6:161927600-161928600 | Enhancers | Fetal Muscle Leg | muscle |
6 | chr6:161927800-161928400 | Enhancers | Fetal Kidney | kidney |
7 | chr6:161927800-161928800 | Enhancers | HSMM | muscle |
8 | chr6:161928000-161928200 | ZNF genes & repeats | Psoas Muscle | Psoas |
9 | chr6:161928000-161928600 | Enhancers | Left Ventricle | heart |
10 | chr6:161928000-161928800 | Enhancers | HSMMtube | muscle |
11 | chr6:161928200-161937000 | Weak transcription | Psoas Muscle | Psoas |
12 | chr6:161928400-161932600 | Weak transcription | Fetal Kidney | kidney |
13 | chr6:161928600-161932600 | Weak transcription | Left Ventricle | heart |
14 | chr6:161928800-161929000 | Bivalent Enhancer | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
15 | chr6:161928800-161929000 | Bivalent Enhancer | H9 Derived Neuron Cultured Cells | ES cell derived |